Open AccessA pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension
Author(s) -
Navreet Kaur Natt,
Anita Gupta,
Garima Singh,
Tej Bali Singh
Publication year - 2014
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/0301-4738.149134
Subject(s) - brimonidine , bimatoprost , medicine , open angle glaucoma , glaucoma , ocular hypertension , ophthalmology , intraocular pressure , eye drop , anesthesia
The aim was to compare efficacy and cost-effectiveness of bimatoprost 0.03% and brimonidine 0.2% in primary open-angle glaucoma (POAG)/ocular hypertension (OHT).